Dr. Mark Gordon on ivermectin: what the evidence says · JRE #2262
SUBJECT: IVERMECTIN
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
Gleason is the grade of cancer of the prostate, and it was Gleason 7. He went on 12 milligrams of ivermectin every day for eight weeks, and at 12 weeks, he got a PET scan done, a special PET scan done, looking at abnormalities in the prostate. They couldn't find anything. That's amazing.
What the evidence says 01 / RECORD
This is a single, uncontrolled anecdote, and it is not supported by controlled clinical evidence. Peer-reviewed reviews state that ivermectin has not been clinically evaluated in cancer patients and remains established only as an antiparasitic, with no large-scale randomized controlled trials confirming any anticancer benefit. Research on ivermectin in prostate cancer is exclusively preclinical, conducted in cell lines and xenograft mice, and the investigators themselves call for future clinical evaluation rather than reporting any cure in patients. A single patient's PET result cannot establish that ivermectin cleared his cancer, especially without molecular confirmation or a controlled comparison, and no evidence shows ivermectin cures or clears Gleason 7 prostate cancer.